NRBO实时信号 | 通过Getagraph.com最大化利润

购买 107741 min ago

@ $4.65

发出时间: 15 Feb 2024 @ 04:13

回报率: -32.49%

上一信号: Feb 12 - 22:45

上一信号: 出售

回报率: -4.12 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:41):

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases...

Stats
今日成交量	4 896.00
平均成交量	1.35M
市值	15.40M
EPS	$-2.28 ( 2024-04-04 )
下一个收益日期	( $-0.950 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.280
ATR14	$0.0240 (0.77%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Woodworth Marshall H	Buy	33 496	Common Stock
2023-12-01	Tursi James Patrick	Buy	7 157	Common Stock
2023-12-01	Tursi James Patrick	Buy	25 000	Common Stock
2023-11-01	Tursi James Patrick	Buy	0
2023-10-27	Woodworth Marshall H	Buy	0

INSIDER POWER
33.02
Last 74 transactions
Buy: 14 405 360 \| Sell: 2 893 741

Neurobo Pharmaceuticals 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Neurobo Pharmaceuticals 财务报表

Annual	2023
营收:	$7 000.00
毛利润:	$0 (0.00 %)
EPS:	$-2.46

FY	2023
营收:	$7 000.00
毛利润:	$0 (0.00 %)
EPS:	$-2.46

FY	2022
营收:	$0
毛利润:	$-28 000.00 (0.00 %)
EPS:	$-19.01

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-28.27

Financial Reports:

No articles found.

Neurobo Pharmaceuticals

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.